CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
3.720
+0.080 (2.20%)
At close: Jul 26, 2024, 4:00 PM
3.760
+0.040 (1.08%)
After-hours: Jul 26, 2024, 6:49 PM EDT

CureVac Revenue

CureVac had revenue of 12.37M EUR in the quarter ending March 31, 2024, with 73.56% growth. This brings the company's revenue in the last twelve months to 59.00M, up 17.59% year-over-year. In the year 2023, CureVac had annual revenue of 53.76M, down -20.26%.

Revenue (ttm)
59.00M EUR
Revenue Growth
+17.59%
P/S Ratio
13.01
Revenue / Employee
50,343 EUR
Employees
1,172
Market Cap
834.42M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202353.76M-13.66M-20.26%
Dec 31, 202267.42M-35.57M-34.54%
Dec 31, 2021102.99M54.12M110.74%
Dec 31, 202048.87M31.46M180.61%
Dec 31, 201917.42M4.55M35.31%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InnovAge Holding 741.33M
Cytek Biosciences 200.79M
Standard BioTools 126.76M
Simulations Plus 66.98M
Mesoblast 7.25M
Dianthus Therapeutics 2.26M
Perspective Therapeutics -304.00K
Revenue Rankings